Presence and maturity of dendritic cells in melanoma lymph node metastases

Journal of Pathology

Volumn 207, Issue 1, 2005, Pages 83-90

  Polak, Marta E ^a,b   Johnson, Penny ^a   Di Palma, Silvana ^c   Higgins, Bernie ^d   Hurren, Jeremy ^a   Borthwick, Nicola J ^e   Jager, Martine J ^b   Mccormick, Deirdre ^a   Cree, Ian A ^a,e  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dendritic cell; Image analysis; Immunosuppression; Melanoma associated lymph nodes; Metastatic melanoma

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CD40 ANTIGEN; CD83 ANTIGEN; HLA DR ANTIGEN; TUMOR ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPH NODE METASTASIS; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE SECTION;

ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD40; CELL DIFFERENTIATION; DENDRITIC CELLS; FACTOR XIIIA; HLA-DR ANTIGENS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOGLOBULINS; LYMPHATIC METASTASIS; MELANOMA; MEMBRANE GLYCOPROTEINS; SKIN NEOPLASMS;

EID: 23944480899     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1809     Document Type: Article

References (29)

1. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90:3245-3287.
2. Schuler G, Schuler-Thurner B, Steinman RM. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003; 15:138-147.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
4. Banchereau J, Paczesny S, Blanco P, Bennett L, Pascual V, Fay J, et al. Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann N Y Acad Sci 2003; 987:180-187.
5. Steinman RM. The control of immunity and tolerance by dendritic cell. Pathol Biol (Paris) 2003;51:59-60.
6. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002;23:445-449.
7. Vermi W, Bonecchi R, Facchetti F, Bianchi D, Sozzani S, Festa S, et al. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J Pathol 2003;200:255-268.
8. Cochran AJ. Melanoma metastases through the lymphatic system. Surg Clin North Am 2000;80:1683-1693.
9. Callery C, Cochran AJ, Roe DJ, Rees W, Nathanson SD, Benedetti JK, et al. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg 1982;196:69-75.
10. Hughes TM, A'Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 2000;87:892-901.
11. Cochran AJ, Pihl E, Wen DR, Hoon DS, Korn EL. Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies. J Natl Cancer Inst 1987; 78:399-405.
12. Hoon DS, Korn EL, Cochran AJ. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans. Cancer Res 1987;47:1740-1744.
13. Lana AM, Wen DR, Cochran AJ. The morphology, immunophenotype and distribution of paracortical dendritic leucocytes in lymph nodes regional to cutaneous melanoma. Melanoma Res 2001; 11:401-410.
14. Essner R, Kojima M. Dendritic cell function in sentinel nodes. Oncology (Huntington) 2002;16(1 Suppl 1):27-31.
15. Cochran AJ, Morton DL, Stern S, Lana AM, Essner R, Wen DR. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol 2001;14:604-608.
16. Cerio R, Griffiths CE, Cooper KD, Nickoloff BJ, Headington JT. Characterization of Factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 1989;121:421-431.
17. Payne AS, Cornelius LA. The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol 2002; 118:915-922.
18. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000;67:2-17.
19. Schwartz RH. T cell anergy. Annu Rev Immunol 2003; 21:305-334.
20. Slidders W, Robertson AJ, Livesey AE, Cree IA, Brown RA, Beck IS. A study of the histological basis of textural analysis. Microsc Acta 1981;84:361-378.
21. Enk AH, Jonuleit H, Saloga J, Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastasic melanoma. Int J Cancer 1997;73:309-316.
22. Whiteside TL, Stanson J, Shurin MR, Ferrone S. Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells. J Immunol 2004; 173:1526-1534.
23. Mehrotra S, Stevens R, Zengou R, Chakraborty NG, Butterfield LH, Economou JS, et al. Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro. Cancer Res 2003;63:5607-5614.
24. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nature Immunol 2001;2:816-822.
25. Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 2003;98:1089-1099.
26. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003;9(12):4404-4408.
27. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10(9):942-949.
28. den Brok MH, Sutmuller RP, van d V, Bennink EJ, Figdor CG, Ruers TJ, et al. In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 2004; 64(11):4024-4029.
29. Vuylsteke RJ, Molenkamp BG, Gietema HA, van Leeuwen PA, Wijnands PG, Vos W, et al. Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma. Cancer Res 2004;64(22):8456-8460.